EcoR1 Capital Fund Qualified L.P. 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-30 4:20 pm Purchase | 2023-06-22 | 13G | Aeglea BioTherapeutics, Inc. AGLE | EcoR1 Capital Fund Qualified L.P. | 200,000 6.400% | 200,000 (New Position) | Filing |